Items where Division is "03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)"
Number of items at this level: 78. 31 May 2016Kastien-Hilka, Tanja and Rosenkranz, Bernd and Bennett, Bryan and Sinanovic, Edina and Schwenkglenks, Matthias. (2016) How to evaluate health-related quality of life and its association with medication adherence in pulmonary tuberculosis - designing a prospective observational study in South Africa. Frontiers in pharmacology, 6. p. 125. 2015Kovacevic, A. and Dragojecic-Simic, V. and Rancic, N. and Jurisevic, M. and Gutzwiller, F. and Matter-Walstra, K. and Jakovljevic, M.. (2015) End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit Pregl, 72 (4). pp. 334-341. Köberle, D. and Betticher, D. C. and von Moos, R. and Dietrich, D. and Brauchli, B. and Baertschi, D. and Matter, K. and Winterhalder, R. and Borner, M. and Anchisi, S. and Moosmann, P. and Kollar, A. and Saletti, P. and Roth, A. and Frueh, M. and Kueng, M. and Popescu, R. A. and Schacher, S. and Hess, V. and Herrmann, R.. (2015) Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26 (4). pp. 709-714. Matter-Walstra, K. and Achermann, R. and Rapold, R. and Klingbiel, D. and Bordoni, A. and Dehler, S. and Jundt, G. and Konzelmann, I. and Clough-Gorr, K. and Szucs, T. and Pestalozzi, B. and Schwenkglenks, M.. (2015) Cancer-Related Therapies at the End of Life in Hospitalized Cancer Patients from Four Swiss Cantons : SAKK 89/09. Oncology, 88 (1). pp. 18-27. Matter-Walstra, K. W. and Greiner, M. and Cusini, A. and Schiesser, M. and Ledergerber, B. and Fehr, T. and Mueller, N. J.. (2015) Stringent adherence to a cytomegalovirus-prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation. Transplant infectious disease, Vol. 17, H. 3. pp. 342-349. Pfeil, Alena M. and Allcott, Kim and Pettengell, Ruth and von Minckwitz, Gunter and Schwenkglenks, Matthias and Szabo, Zsolt. (2015) Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer : a systematic review. Supportive care in cancer, Vol. 23, H. 2. pp. 525-545. Pfeil, Alena M. and Imfeld, P. and Pettengell, R. and Jick, S. S. and Szucs, Thomas D. and Meier, Christoph R. and Schwenkglenks, Matthias. (2015) Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia : insights from the UK Clinical Practice Research Datalink (CPRD). Annals of hematology, 94 (3). pp. 421-429. Pfeil, Alena Maria. Neutropenia in cancer patients, risk prediction models of neutropenia, and supportive measures. 2015, Doctoral Thesis, University of Basel, Faculty of Science. 2014Jakovljevic, Mihajlo and Gutzwiller, Florian S. and Schwenkglenks, Matthias and Milovanovic, Olivera and Rancic, Nemanja and Varjacic, Mirjana and Stojadinovic, Dobrivoje and Dagovic, Aleksandar and Matter-Walstra, Klazien. (2014) Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. JBUON, 19 (3). pp. 1111-1120. Joerger, M. and Schaer-Thuer, C. and Koeberle, D. and Matter-Walstra, K. and Gibbons-Marsico, J. and Diem, S. and Thuerlimann, B. and Cerny, T.. (2014) Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study. European Journal of Clinical Pharmacology, 70 (6). p. 719. Matter-Walstra, K. and Klingbiel, D. and Szucs, T. and Pestalozzi, B. C. and Schwenkglenks, M.. (2014) Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied? PharmacoEconomics, Vol. 32, no. 6. pp. 591-599. Matter-Walstra, K. M. and Achermann, R. and Rapold, R. and Klingbiel, D. and Bordoni, A. and Dehler, S. and Jundt, G. and Konzelmann, I. and Clough-Gorr, K. and Szucs, T. and Schwenkglenks, M. and Pestalozzi, B. C.. (2014) Delivery of health care at the end of life in cancer patients of four swiss cantons : a retrospective database study (SAKK 89/09). BMC cancer, Vol. 14. pp. 306-317. Pavic, Matea and Pfeil, Alena M. and Szucs, Thomas D.. (2014) Estimating the potential annual welfare impact of innovative drugs in use in Switzerland. Frontiers in public health, 2. Article 48. Pfeil, Alena M. and Vulsteke, Christof and Paridaens, Robert and Dieudonné, Anne-Sophie and Pettengell, Ruth and Hatse, Sigrid and Neven, Patrick and Lambrechts, Diether and Szucs, Thomas D. and Schwenkglenks, Matthias and Wildiers, Hans. (2014) Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC cancer, Vol. 14. p. 201. Schwenkglenks, Matthias and Gerbershagen, Hans J. and Taylor, Rod S. and Pogatzki-Zahn, Esther and Komann, Marcus and Rothaug, Judith and Volk, Thomas and Yahiaoui-Doktor, Maryam and Zaslansky, Ruth and Brill, Silviu and Ullrich, Kristin and Gordon, Debra B. and Meissner, Winfried. (2014) Correlates of satisfaction with pain treatment in the acute postoperative period : Results from the international PAIN OUT registry. Pain, Vol. 155, H. 7. pp. 1401-1411. Vulsteke, C. and Pfeil, A. M. and Schwenkglenks, M. and Pettengell, R. and Szucs, T. D. and Lambrechts, D. and Peeters, M. and van Dam, P. and Dieudonné, A. S. and Hatse, S. and Neven, P. and Paridaens, R. and Wildiers, H.. (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment, Vol. 147, H. 3. pp. 557-570. 2013Bollhalder, Lea and Pfeil, Alena M. and Tomonaga, Yuki and Schwenkglenks, Matthias. (2013) A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clinical nutrition, Vol. 32, H. 2. pp. 213-223. Gutzwiller, Florian S. and Pfeil, Alena M. and Comin-Colet, Josep and Ponikowski, Piotr and Filippatos, Gerasimos and Mori, Claudio and Braunhofer, Peter G. and Szucs, Thomas D. and Schwenkglenks, Matthias and Anker, Stefan D.. (2013) Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose : FAIR-HF sub-analysis. International journal of cardiology, Vol. 168, H. 4. pp. 3878-3883. Lothgren, Mickael and Ribnicsek, Erna and Schmidt, Louise and Habacher, Wolfgang and Lundkvist, Jonas and Pfeil, Alena M. and Biteeva, Irina and Vrouchou, Polina and Bracco, Andrea. (2013) Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland. European journal of hospital pharmacy. Science and practice, Vol. 20, H. 4. pp. 227-231. Rothaug, Judith and Zaslansky, Ruth and Schwenkglenks, Matthias and Komann, Marcus and Allvin, Renée and Backström, Ragnar and Brill, Silviu and Buchholz, Ingo and Engel, Christoph and Fletcher, Dominique and Fodor, Lucian and Funk, Peter and Gerbershagen, Hans J. and Gordon, Debra B. and Konrad, Christoph and Kopf, Andreas and Leykin, Yigal and Pogatzki-Zahn, Esther and Puig, Margarita and Rawal, Narinder and Taylor, Rod S. and Ullrich, Kristin and Volk, Thomas and Yahiaoui-Doktor, Maryam and Meissner, Winfried. (2013) Patients' perception of postoperative pain management : validation of the International Pain Outcomes (IPO) questionnaire. Journal of pain, Vol. 14, H. 11. pp. 1361-1370. Schwenkglenks, Matthias and Bendall, Kate Louise and Pfeil, Alena M. and Szabo, Zsolt and Pettengell, Ruth. (2013) External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & lymphoma, Vol. 54, H. 11. pp. 2426-2432. Szucs, Thomas D. and Pfeil, Alena M.. (2013) A systematic review of the cost effectiveness of herpes zoster vaccination. PharmacoEconomics, Vol. 31, no. 2. pp. 125-136. Taylor, Rod S. and Ullrich, Kristin and Regan, Sophie and Broussard, Christina and Schwenkglenks, Matthias and Taylor, Rebecca J. and Gordon, Debra B. and Zaslansky, Ruth and Meissner, Winfried and Rothaug, Judith and Langford, Richard and Pain-OUT investigators, . (2013) The impact of early postoperative pain on health-related quality of life. Pain practice, Vol. 13, H. 7. pp. 515-523. 2012Gutzwiller, Florian S. and Biller-Andorno, Nikola and Harnacke, Caroline and Bollhalder, Lea and Szucs, Thomas D. and Gutzwiller, Felix and Schwenkglenks, Matthias. (2012) Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und deren Anwendung in der Schweiz und ausgewählten europäischen Ländern. Bern. Gutzwiller, Florian S. and Schwenkglenks, Matthias and Blank, Patricia R. and Braunhofer, Peter G. and Mori, Claudio and Szucs, Thomas D. and Ponikowski, Piotr and Anker, Stefan D.. (2012) Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. European journal of heart failure, Vol. 14, H. 7. pp. 782-790. Matter-Walstra, Klazien and Joerger, Markus and Kühnel, Ursula and Szucs, Thomas and Pestalozzi, Bernhard and Schwenkglenks, Matthias. (2012) Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the swiss health care system. Value in health, Vol. 15, H. 1. pp. 65-71. Moch, H. and Blank, P. R. and Dietel, M. and Elmberger, G. and Kerr, K. M. and Palacios, J. and Penault-Llorca, F. and Rossi, G. and Szucs, T. D.. (2012) Personalized cancer medicine and the future of pathology. Virchows Archiv, Vol. 460. pp. 3-8. Pettengell, Ruth and Johnson, Hans E. and Lugtenburg, Pieternella J. and Silvestre, Antonio Salar and Dührsen, Ulrich and Rossi, Francesca G. and Schwenkglenks, Matthias and Bendall, Kate and Szabo, Zsolt and Jaeger, Ulrich. (2012) Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Vol. 20, H. 3. pp. 647-652. Pfeil, Alena M. and Kressig, Reto W. and Szucs, Thomas D.. (2012) Alzheimer's dementia : budget impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland. Swiss medical weekly, Vol. 142 , w13676. 2011Blank, Patricia R. and Moch, Holger and Szucs, Thomas D. and Schwenkglenks, Matthias. (2011) KRAS and BRAF mutation analysis in metastatic colorectal cancer : a cost-effectiveness analysis from a Swiss perspective. Clinical cancer research, Vol. 17, no. 19. pp. 6338-6346. Egevad, Lars and Algaba, Ferran and Berney, Daniel M. and Boccon-Gibod, Liliane and Compérat, Eva and Evans, Andrew J. and Grobholz, Rainer and Kristiansen, Glen and Langner, Cord and Lockwood, Gina and Lopez-Beltran, Antonio and Montironi, Rodolfo and Oliveira, Pedro and Schwenkglenks, Matthias and Vainer, Ben and Varma, Murali and Verger, Vincent and Camparo, Philippe. (2011) Interactive digital slides with heat maps : a novel method to improve the reproducibility of Gleason grading. Virchows Archiv, Vol. 459, H. 2. pp. 175-182. Evstatiev, Rayko and Marteau, Philippe and Iqbal, Tariq and Khalif, Igor L. and Stein, Jürgen and Bokemeyer, Bernd and Chopey, Ivan V. and Gutzwiller, Florian S. and Riopel, Lise and Gasche, Christoph and Fergi Study Group, . (2011) FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology, Vol. 141, H. 3 , S. 846-853.e1-2. Farshad, Mazda and Gerber, Christian and Meyer, Dominik C. and Schwab, Alexander and Blank, Patricia R. and Szucs, Thomas. (2011) Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament : cost effectiveness analysis. BMC health services research, Vol. 11 , 317. Haioun, Corinne and Salar, Antonio and Pettengell, Ruth and Johnsen, Hans Erik and Duehrsen, Ulrich and Rossi, Francesca Gaia and Verhoef, Gregor and Schwenkglenks, Matthias and Jaeger, Ulrich and Hamilton, Lisa and Pujol, Beatriz and Lugtenburg, Pieternella Johanna. (2011) Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy : results from an observational study. Leukemia & lymphoma, Vol. 52, H. 5. pp. 796-803. Joerger, M. and Matter-Walstra, K. and Früh, M. and Kühnel, U. and Szucs, T. and Pestalozzi, B. and Schwenkglenks, M.. (2011) Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer : a cost-utility analysis. Annals of Oncology, Vol. 22, H. 3. pp. 567-574. Loibl, Sibylle and Skacel, Tomas and Nekljudova, Valentina and Lück, Hans Joachim and Schwenkglenks, Matthias and Brodowicz, Thomas and Zielinski, Christoph and von Minckwitz, Gunter. (2011) Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis. BMC cancer, Vol. 11. p. 131. Pettengell, R. and Schwenkglenks, M. and Bacon, P. and Lawrinson, S. and Duehrsen, U.. (2011) Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma : results from an integrated analysis. Hematological oncology, Vol. 29, H. 4. pp. 177-184. Pettengell, Ruth and Schwenkglenks, Matthias. (2011) Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups. Leukemia [and] lymphoma, Vol. 52, H. 6. pp. 1133-1136. Schwenkglenks, Matthias and Brazier, John E. and Szucs, Thomas D. and Fox, Keith A. A.. (2011) Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. Value in health, Vol. 14, H. 1. pp. 24-33. Schwenkglenks, Matthias and Pettengell, Ruth and Jackisch, Christian and Paridaens, Robert and Constenla, Manuel and Bosly, André and Szucs, Thomas D. and Leonard, Robert. (2011) Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study. Supportive care in cancer, Vol. 19, H. 4. pp. 483-490. Szucs, T. D. and Blank, P. R. and Schwenkglenks, M. and Aapro, M.. (2011) Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81 (1). pp. 45-49. Tomonaga, Yuki and Gutzwiller, Felix and Lüscher, Thomas F. and Riesen, Walter F. and Hug, Markus and Diemand, Albert and Schwenkglenks, Matthias and Szucs, Thomas D.. (2011) Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care : a cluster-randomised controlled trial. BMC family practice, Vol. 12. p. 12. 2010Aapro, Matti and Schwenkglenks, Matthias and Lyman, Gary H. and Lopez Pousa, Antonio and Lawrinson, Susan and Skacel, Tomas and Bacon, Pamela and von Minckwitz, Gunter. (2010) Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy. Critical reviews in oncology, hematology, Vol. 74, H. 3. pp. 203-210. Blank, Patricia R. and Blank, Armin A. and Szucs, Thomas D.. (2010) Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema : a long-term analysis from a Swiss perspective. BMC dermatology, Vol. 10. p. 4. Blank, Patricia R. and Dedes, Konstantin J. and Szucs, Thomas D.. (2010) Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer : a critical and systematic review. PharmacoEconomics, Vol. 28, no. 8. pp. 629-647. Blank, Patricia R. and Schwenkglenks, Matthias and Moch, Holger and Szucs, Thomas D.. (2010) Human epidermal growth factor receptor 2 expression in early breast cancer patients : a Swiss cost-effectiveness analysis of different predictive assay strategies. Breast cancer research and treatment, Vol. 124, H. 2. pp. 497-507. Matter-Walstra, K. W. and Dedes, K. J. and Schwenkglenks, M. and Brauchli, P. and Szucs, T. D. and Pestalozzi, B. C.. (2010) Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21 (11). pp. 2161-2168. Pfeil, Alena and Mutsch, Margot and Hatz, Christoph and Szucs, Thomas D.. (2010) A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations. BMC Public Health, 10. p. 402. Romanens, Michel and Ackermann, Franz and Spence, John David and Darioli, Roger and Rodondi, Nicolas and Corti, Roberto and Noll, Georg and Schwenkglenks, Matthias and Pencina, Michael. (2010) Improvement of cardiovascular risk prediction : time to review current knowledge, debates, and fundamentals on how to assess test characteristics. European Journal of Cardiovascular Prevention and Rehabilitation, 17 (1). pp. 18-23. Schwenkglenks, Matthias and Pettengell, Ruth and Szucs, Thomas D. and Culakova, Eva and Lyman, Gary H.. (2010) Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. Journal of hematology & oncology, Vol. 3. p. 27. Widmer, Lukas L. and Blank, Patricia R. and Van Herck, Koen and Hatz, Christoph and Schlagenhauf, Patricia. (2010) Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC infectious diseases, Vol. 10. p. 279. 2009Blank, P. R. and Schwenkglenks, M. and Szucs, T. D.. (2009) Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons. Infection, 37. pp. 390-400. Blank, Patricia R. and Schwenkglenks, Matthias and Szucs, Thomas D.. (2009) Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. The journal of infection, Vol. 58. pp. 446-458. Blank, Patricia R. and Szucs, Thomas D.. (2009) Increasing influenza vaccination coverage in recommended population groups in Europe. Expert review of vaccines, Vol. 8, H. 4. pp. 425-433. Dedes, Konstantin J. and Matter-Walstra, Klazien and Schwenkglenks, Matthias and Pestalozzi, Bernhard C. and Fink, Daniel and Brauchli, Peter and Szucs, Thomas D.. (2009) Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer : an economic evaluation. EJC : European journal of cancer, Vol. 45, H. 8. pp. 1397-1406. Endrich, Michael M. and Blank, Patricia R. and Szucs, Thomas D.. (2009) Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine : the official journal of the International Society for Vaccines, Vol. 27. pp. 4018-4024. McCann, S. and Schwenkglenks, M. and Bacon, P. and Einsele, H. and D'Addio, A. and Maertens, J. and Niederwieser, D. and Rabitsch, W. and Roosaar, A. and Ruutu, T. and Schouten, H. and Stone, R. and Vorkurka, S. and Quinn, B. and Blijlevens, N. and Ebmt Mucositis Advisory Group, . (2009) The Prospective Oral Mucositis Audit : relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone marrow transplantation, Vol. 43. pp. 141-147. Pettengell, Ruth and Bosly, André and Szucs, Thomas D. and Jackisch, Christian and Leonard, Robert and Paridaens, Robert and Constenla, Manuel and Schwenkglenks, Matthias and Impact of Neutropenia in Chemotherapy-European Study Group, . (2009) Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma : data from the INC-EU Prospective Observational European Neutropenia Study. British journal of haematology : the official journal of the British Society for Haematology and the European Haematology Association, Vol. 144. pp. 677-685. Romanens, Michel and Ackermann, Franz and Abay, Michael and Szucs, Thomas and Schwenkglenks, Matthias. (2009) Agreement of Swiss-adapted international and European guidelines for the assessment of global vascular risk and for lipid lowering interventions. Cardiovascular drugs and therapy, Vol. 23. pp. 249-254. von Minckwitz, G. and Schwenkglenks, M. and Skacel, T. and Lyman, G. H. and Pousa, A. Lopez and Bacon, P. and Easton, V. and Aapro, M. S.. (2009) Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management : results from an integrated analysis. European journal of cancer, Vol. 45, H. 4. pp. 608-617. 2008Blank, Patricia R. and Freiburghaus, Andreas U. and Ruf, Bernhard R. and Schwenkglenks, Matthias M. and Szucs, Thomas D.. (2008) Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07. Medizinische Klinik, 103 (11). pp. 761-768. Blank, Patricia R. and Freiburghaus, Andreas U. and Schwenkglenks, Matthias M. and Szucs, Thomas D. and Kunze, Ursula. (2008) Influenza vaccination coverage rates in Austria in 2006/07 - a representative cross-sectional telephone survey. Wiener medizinische Wochenschrift, Vol. 158, H. 19-20. pp. 583-588. Blank, Patricia R. and Schwenkglenks, Matthias and Szucs, Thomas D.. (2008) Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health, Vol. 8. p. 272. Blijlevens, Nicole and Schwenkglenks, Matthias and Bacon, Pamela and D'Addio, Alessandra and Einsele, Hermann and Maertens, Johan and Niederwieser, Dietger and Rabitsch, Werner and Roosaar, Ann and Ruutu, Tapani and Schouten, Harry and Stone, Rebecca and Vokurka, Samuel and Quinn, Barry and McCann, Shaun and European Blood, and Marrow Transplantation Mucositis Advisory Group, . (2008) Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group. Journal of clinical oncology, Vol. 26. pp. 1519-1525. Matter-Walstra, KW. and Szucs, T. and Brauchli, P. and Schwenkglenks, M.. (2008) Randomisiert-kontrollierte Studien von Krebstherapien in der Schweiz. Outcomes Research und gesundheitsökonomische Aspekte. Schweizerische Ärztezeitung, 89 (36). pp. 1545-1549. Matter-Walstra, Klazien and Schoeni-Affolter, Franziska and Widmer, Marcel and Busato, André. (2008) Patient-based evaluations of primary care for cardiovascular diseases: a comparison between conventional and complementary medicine. Journal of Evaluation in Clinical Practice , 14 (1). pp. 75-82. Pettengell, R. and Schwenkglenks, M. and Bosly, A.. (2008) Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy. Annals of hematology, Vol. 87, issue 5. pp. 429-430. Pettengell, Ruth and Schwenkglenks, Matthias and Leonard, Robert and Bosly, André and Paridaens, Robert and Constenla, Manuel and Szucs, Thomas D. and Jackisch, Christian and Impact of Neutropenia in Chemotherapy-European Study Group, . (2008) Neutropenia occurrence and predictors of reduced chemotherapy delivery : results from the INC-EU prospective observational European neutropenia study. Supportive care in cancer, Vol. 16, H. 11. pp. 1299-1309. 2007Berberat, C. and Matter-Walstra, K. and Schöni-Affolter, F. and Künzi, B. and Busato, A.. (2007) Behandlungsqualität von Hausärzten in Einzel- und Gruppenpraxen der Schweiz. Schweizerische Ärztezeitung, 88 (42). pp. 1762-1768. Matter-Walstra, K. and Widmer, M. and Schoeni-Affolter, F. and Balmer, C. and Busato, A.. (2007) Analyse der Hauptbehandlungskodierung der medizinischen Statistik für orthopädische Behandlungen mittels Spitaleinzugsgebieten (small area analysis). Schweizerische Ärztezeitung, 88 (45). pp. 1-8. Matter-Walstra, K. and Widmer, M. and Schoeni-Affolter, F. and Balmer, C. and Busato, A.. (2007) Die medizinische Statistik für orthopädische Behandlungen. Schweizerische Ärztezeitung, 88 (45). pp. 1907-1908. Matter-Walstra, K. W. and Künzi, B.. (2007) Ärztenetzwerke im Kanton Bern / nur Hoffnung oder die Realität von morgen? Schweizerische Ärztezeitung, 88 (44). pp. 1853-1862. Schoeni-Affolter, F. and Matter-Walstra, K. and Widmer, M. and Busato, A.. (2007) Satisfaction with primary health care in patients with upper respiratory tract infection: a three-level approach. Complementary Medicine Research, 14 (6). pp. 346-352. 2006Matter-Walstra, K. and Widmer, M. and Busato, A.. (2006) Seasonal variation in orthopedic health services utilization in Switzerland: the impact of winter sport tourism. BMC Health Services Research, 6. p. 25. Matter-Walstra, Klazien and Widmer, Marcel and Busato, André. (2006) Analysis of patient flows for orthopedic procedures using small area analysis in Switzerland. BMC Health Services Research, 6. p. 119. 2001Matter-Walstra, K. W. and Hoffrage, U.. (2001) Individuelle Entscheidungsfindung am Beispiel der Brustkrebs-Früherkennung: Erfahrungen aus Fokusgruppen in der Schweiz. Care Management, 3 (5). pp. 26-29. 1996Matter-Walstra, K. W. and Kraft, R.. (1996) Atypical cells in effusions: diagnostic value of cell image analysis combined with immunocytochemistry. Diagn Cytopathol, 15 (4). pp. 263-269. 1985Walstra, K. and Gratwohl, A. and Riederer, I. and Speck, B.. (1985) B/T cell ratio of rabbit peripheral blood lymphocytes : influence of separation technique on results. Journal of immunological methods, Vol. 79, H. 1. pp. 143-147. |
